Here’s a shocking revelation that’s bound to spark debate: New York City’s public hospitals are funneling millions of dollars into Palantir, a company notorious for its ties to ICE and the military. Yes, you read that right. The same firm that’s been at the center of mass deportations, warfare, and surveillance is now deeply embedded in the city’s healthcare system. But here’s where it gets controversial: Palantir isn’t just crunching numbers—it’s analyzing patient data to maximize billing efficiency, including scanning health notes to uncover missed charges. Sounds like a win for hospital finances, right? Not so fast. Critics argue this partnership crosses a dangerous line, blending the business of healing with the ethics of a company accused of enabling human rights abuses.
Since 2023, the New York City Health and Hospitals Corporation has paid Palantir nearly $4 million to streamline Medicaid billing and other public benefit processes. On the surface, this might seem like a practical move to ensure hospitals get paid for their services. But this is the part most people miss: Palantir’s software doesn’t just stop at billing. It has access to protected health information (PHI), which, despite being de-identified, raises serious concerns about patient privacy. Activists warn that de-identified data can often be re-identified with alarming ease, putting vulnerable populations—like undocumented immigrants—at risk.
Palantir’s dual role as a healthcare partner and a tool for ICE has ignited fierce backlash. Kenny Morris, an organizer with the American Friend Service Committee, bluntly states, ‘It’s unacceptable that the same company targeting our neighbors for deportation is also handling our hospitals’ software.’ Beth Haroules of the New York Civil Liberties Union echoes this sentiment, calling the contract ‘reckless’ and a threat to countless lives. She emphasizes that every New Yorker deserves healthcare without fearing their medical or immigration status will be handed over to federal authorities.
And this isn’t just a local issue. Palantir’s involvement with the U.K.’s National Health Service has faced growing criticism, with Green Party leader Zack Polanski declaring the company has ‘absolutely no place’ in patient data management. Back in New York, organizations like the Climate Organizing Hub argue that Palantir’s presence directly undermines the trust of the very communities the hospitals aim to serve. Jonathan Westin puts it starkly: ‘Palantir is targeting the exact patients that NYCHH is looking to serve.’
But here’s the bigger question: Can a company with such a controversial track record ever truly separate its healthcare work from its other ventures? Palantir insists it doesn’t misuse hospital data, but its history with ICE, the NSA, and even the Israeli military during the Gaza conflict leaves many skeptical. Hannah Drummond, a nurse and organizer, sums it up: ‘As a nurse, I don’t want anything to do with Palantir in my hospital.’
Adding another layer of complexity, Palantir’s CEO, Alex Karp, is a vocal critic of New York City’s democratic socialist Mayor Zohran Mamdani. While the mayor’s office hasn’t commented on the contract, the political undertones are hard to ignore. Is this a clash of ideologies, or simply a matter of practicality in a cash-strapped healthcare system?
What do you think? Is Palantir’s role in New York’s hospitals a necessary evil, or a dangerous overreach? Should the city sever ties with the company, even if it means losing efficiency in billing? Let’s hear your thoughts in the comments—this is one debate that’s far from over.
